Antimicrobial Regimens in Cement Spacers for Periprosthetic Joint Infections: A Critical Review.
Symeon NaoumChristos KoutserimpasPantekidis IoannisVasileios GiovanoulisEnejd VeiziMaria PiagkouPetros IoannouGeorge SamonisAglaia DomouchtsidouAndreas G TsantesDimitrios V PapadopoulosPublished in: Antibiotics (Basel, Switzerland) (2024)
Antibiotic-loaded cement spacers (ALCSs) are essential for treating periprosthetic joint infections (PJIs) by providing mechanical support and local antibiotic delivery. The purpose of this review is to comprehensively examine the various types of spacers utilised in the management of periprosthetic joint infections (PJIs), including both static and articulating variants and to analyse the fundamental principles underlying spacer use, their clinical benefits, the selection and administration of antimicrobial agents, appropriate dosages, and potential adverse effects. Articulating spacers, which allow joint mobility, often yield better outcomes than static ones. Spacer pharmacokinetics are vital for maintaining therapeutic antibiotic levels, influenced by cement porosity, mixing techniques, and the contact area. Antibiotic choice depends on heat stability, solubility, and impact on cement's mechanical properties. Mechanical properties are crucial, as spacers must withstand physical stresses, with antibiotics potentially affecting these properties. Complications, such as tissue damage and systemic toxicity, are discussed, along with mitigation strategies. Future advancements include surface modifications and novel carriers to enhance biofilm management and infection control.
Keyphrases
- staphylococcus aureus
- total hip
- total hip arthroplasty
- oxidative stress
- pseudomonas aeruginosa
- climate change
- physical activity
- mental health
- risk factors
- type diabetes
- candida albicans
- escherichia coli
- metabolic syndrome
- copy number
- biofilm formation
- adipose tissue
- decision making
- risk assessment
- cancer therapy
- heat stress
- drug induced